CLINICAL UPDATES · SEASON 1 · EPISODE 10

Vaccination in Transplant Recipients and Dialysis Patients

Vaccination protects the patients least able to fight infection — transplant recipients and people on dialysis — but immunosuppression changes both the schedule and which vaccines are safe. This Clinical Update sets out the principles: what to give, when to give it, and why live vaccines are handled differently.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

MedicalVideos Clinical Updates is an educational series produced with full editorial independence. If an episode is sponsor-funded, that funding is labelled on the episode page and on the series hub.

In short: Transplant and dialysis patients face higher infection risk and weaker vaccine responses. The rules: vaccinate as early as possible, use inactivated vaccines after transplant, complete live vaccines beforehand, give hepatitis B special attention in dialysis, and vaccinate household contacts too.

The update

The clinical picture

Infection is one of the leading causes of death in transplant recipients and dialysis patients, and much of it is vaccine-preventable. Uremia itself blunts immune responses; immunosuppressant medicines blunt them further, and also change which vaccines are safe. The result is a two-sided problem: these patients need vaccination more than the general population, yet respond less well and face restrictions the general population does not. A structured vaccine review — ideally before dialysis, always before transplant — is therefore part of standard preparation, covering influenza, pneumococcal disease, hepatitis B, COVID-19, shingles, and the age-appropriate routine schedule.

The current landscape

The organising principles are stable across guidelines, including CDC guidance for altered immunocompetence. First, vaccinate early: the best responses come before transplant and before dialysis, so review starts at CKD care and at transplant assessment. Second, inactivated, subunit, and mRNA vaccines can be given to immunosuppressed patients; live vaccines are generally contraindicated after transplant and are completed beforehand with an appropriate interval. Third, timing after transplant matters: routine vaccination typically resumes once immunosuppression is stable, often a few months in, and influenza vaccine may be given earlier in season. Household contacts should be fully vaccinated to build a protective cocoon.

In practice

In practice, the work is record-keeping and timing. Teams document vaccine history and relevant immunity (such as varicella and measles) at assessment, give missing inactivated vaccines without delaying listing, and schedule live vaccines with the required pre-transplant gap when transplantation is not imminent. Hepatitis B deserves special emphasis in dialysis: a dedicated higher-dose or adjuvanted schedule is used, with antibody levels checked afterwards and boosters given when levels fall. After transplant, the centre's protocol sets when each vaccine resumes; patients are given a written record and told to check before receiving any vaccine elsewhere, including travel vaccines.

When to escalate

Escalate vaccine planning when transplant listing is imminent and the record is incomplete — there may still be time for inactivated vaccines, but live vaccines need a pre-transplant window that closes fast. A household contact receiving a live vaccine, or a patient exposed to measles or chickenpox without immunity, needs same-week advice, since post-exposure options exist but are time-limited. Fever after vaccination in a transplant patient is usually benign, but fever with graft symptoms or in the early post-transplant months should be assessed as possible infection, not assumed to be a vaccine reaction.

Common questions

Why are live vaccines treated differently?

Live vaccines (such as MMR and varicella) are generally avoided after transplant because immunosuppression removes the safety margin. They are given before transplant when possible, with a gap before surgery. Inactivated and subunit vaccines do not carry this concern.

When should dialysis patients be vaccinated?

Ideally before dialysis starts or early in its course — responses are better with less uremia and before transplant immunosuppression begins. Vaccination status is reviewed at dialysis start and at transplant assessment so gaps are caught in time.

Does the flu vaccine change after transplant?

Flu vaccine is recommended every year. Immunosuppressed patients receive the inactivated injection; the live nasal-spray form is not used. Vaccinating household contacts as well adds a protective ring around the patient.

What is the pneumococcal vaccine for?

Pneumococcal vaccination protects against pneumococcal pneumonia and bloodstream infection, to which dialysis and transplant patients are more vulnerable. Schedules combine the available pneumococcal vaccine types in a defined sequence, set by national guidance.

More in Transplant

Related

Related reading

Sources

  • Altered Immunocompetence — Best Practices Guidance (Centers for Disease Control and Prevention (CDC))
  • Vaccines (Immunizations) (MedlinePlus, US National Library of Medicine)
  • Kidney Transplantation (MedlinePlus, US National Library of Medicine)
  • Dialysis (MedlinePlus, US National Library of Medicine)

This Clinical Update is educational content for clinicians and informed patients. It is not medical advice and does not replace the judgment of the treating team. Drug classes are discussed in general terms only; prescribing decisions, doses, and monitoring belong with the patient's own clinicians. Vaccine schedules for immunocompromised patients are set by national guidance and the transplant centre; this page gives principles, not a personal schedule.